Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
The point prevalence survey aims at defining the until now unknown real prevalence of hypophosphatemia (defined as blood phosphate value < 0.8 mmol/l) in international critical care settings
Full description
The survey will be conducted on one single day in each centre (D-day), within a week defined by the project coordinator (International PI). On D-Day, the local investigators will be asked
Enrollment
Sex
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria: blood phosphate value < 0.8 mmol -
Exclusion Criteria: Blood phosphate value >0.8 mmol/l
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal